Business
Alignment Healthcare operates a consumer-centric Medicare Advantage platform for seniors, combining health plans, clinical model, and technology.
Alignment Healthcare revenue rose 46.1% to $3.95B and free cash flow turned positive at $113.1M.
The read at a glance✓ Audited against SEC data
- Business mix — Medicare Advantage platform for seniorsOK
- Revenue — Revenue rose 46.1% to $3.95BOK
- Cash — Free cash flow was $113.1MOK
- Profitability — Net loss narrowed to $0.7MOK
- Balance sheet — Equity rose 79.5%OK
- Insiders — 0 buys / 68 sellsWatch
- Accounting — Altman-Z safe; EQ safeOK
Where the revenue comes from
Fiscal 2025, as Alignment Healthcare, Inc. reports it. History and quarterly detail are in the app.
- Premium$3.9B
- Capitation$5.1M
- Realizing Equity, Access, and Community Health (REACH) Model$1.2M
Leadership changes
From Alignment Healthcare, Inc.'s own filings, the day they're filed.
- Hakan Kardes · Chief Experience Officer · departureeff. 2025-04-09
- Dawn Maroney · President · appointmenteff. 2025-01-13
- Jeffrey Margolis · Directors · departureeff. 2024-08-13
Latest filings
- 10-Q · Quarterly report2026-07-30
- 8-K · Company announcement2026-07-30
- 8-K · Company announcement2026-06-09
- 8-K · Company announcement2026-05-12
- 10-Q · Quarterly report2026-04-30
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Alignment Healthcare, Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.